Antimicrobial Agents Practice Questions

Q: Which antifungal agent is also used as a chemotherapeutic agent for cancer?

Flucytosine. **Explanation:** **Flucytosine (5-Fluorocytosine)** is the correct answer because it is a pyrimidine antimetabolite. Its mechanism of action involves being taken up by fungal cells via the enzyme **cytosine permease** and subsequently converted into **5-fluorouracil (5-FU)** by **cytosine deaminase**. 5-FU is a potent chemotherapeutic agent used in treating various cancers (e.g., colorectal and breast cancer). In fungal cells, 5-FU inhibits thymidylate synthase, disrupting DNA synthesis. While humans lack cytosine deaminase (limiting toxicity), 5-FU itself is a cornerstone of oncology. **Analysis of Incorrect Options:** * **Nystatin:** A polyene antifungal used topically for Candidiasis. It is too toxic for systemic use and has no role in chemotherapy. * **Voriconazole:** A second-generation triazole that inhibits ergosterol synthesis. It is the drug of choice for Invasive Aspergillosis but lacks antineoplastic properties. * **Terbinafine:** An allylamine that inhibits squalene epoxidase. It is primarily used for dermatophytoses (onychomycosis) and is not used in cancer treatment. **High-Yield Clinical Pearls for NEET-PG:** * **Synergy:** Flucytosine is rarely used alone due to rapid resistance; it is most commonly combined with **Amphotericin B** for Cryptococcal meningitis. * **Adverse Effects:** The most significant side effect is **bone marrow suppression** (anemia, leukopenia, thrombocytopenia), which mimics the toxicity of traditional chemotherapy. * **Mechanism Link:** Remember: Flucytosine $\rightarrow$ 5-FU $\rightarrow$ Inhibition of Thymidylate Synthase (Thymineless death).

Q: Which anti-tubercular drug is not typically given to children under 6 years of age?

Ethambutol. **Explanation:** **Ethambutol** is the correct answer because its most significant dose-dependent side effect is **retrobulbar neuritis**, which manifests as decreased visual acuity and a loss of red-green color discrimination [1]. In children under 6 years of age, reliable monitoring of visual acuity and color vision is clinically challenging due to their inability to cooperate with formal ophthalmological testing (like Snellen charts or Ishihara plates) [1]. Therefore, to prevent irreversible vision loss that might go undetected, it is traditionally avoided in young children unless absolutely necessary [1]. **Analysis of Incorrect Options:** * **Isoniazid (B):** A cornerstone of pediatric TB treatment. While it can cause peripheral neuropathy (prevented by Pyridoxine), it is safe and routinely used in all age groups. * **Streptomycin (C):** An aminoglycoside that can cause ototoxicity and nephrotoxicity. While it requires monitoring, it is not contraindicated based on age alone, though it is less preferred due to its injectable route. * **Rifampicin (D):** A primary bactericidal drug used in pediatric regimens. Its main side effect is orange discoloration of secretions and hepatotoxicity, but it is safe for infants and children. **NEET-PG High-Yield Pearls:** * **Mechanism of Action:** Ethambutol inhibits **Arabinosyl transferase**, preventing cell wall synthesis. * **Visual Monitoring:** Patients on Ethambutol should have baseline and monthly visual acuity and color vision checks [1]. * **Hyperuricemia:** Ethambutol decreases the excretion of uric acid and can precipitate **Gout** (similar to Pyrazinamide). * **Bacteriostatic:** Among the first-line ATT (HRZE), Ethambutol is the only drug that is primarily bacteriostatic.

Q: In a patient with culture-positive enterococcal endocarditis who has failed to respond to vancomycin due to resistance, what is the most likely effective treatment?

Linezolid. **Explanation:** The clinical scenario describes a case of **Vancomycin-Resistant Enterococci (VRE)** endocarditis. Enterococci are naturally resilient organisms, and the emergence of VRE (particularly *E. faecium*) poses a significant therapeutic challenge. **Why Linezolid is correct:** Linezolid is an oxazolidinone antibiotic that inhibits protein synthesis by binding to the **23S ribosomal RNA of the 50S subunit**, preventing the formation of the 70S initiation complex. It is a first-line agent for VRE infections. Its unique mechanism of action ensures there is no cross-resistance with other protein synthesis inhibitors. Other alternatives for VRE include Daptomycin and Quinupristin-Dalfopristin. **Why the other options are incorrect:** * **Clarithromycin (Macrolide):** Enterococci exhibit inherent resistance to macrolides; they are never used as monotherapy for endocarditis. * **Minocycline (Tetracycline):** While it has a broad spectrum, it is bacteriostatic and lacks sufficient clinical efficacy against systemic VRE endocarditis. * **Ticarcillin (Antipseudomonal Penicillin):** Enterococci are generally resistant to ticarcillin. While some enterococci are sensitive to Ampicillin, VRE strains are almost always resistant to all beta-lactams. **High-Yield NEET-PG Pearls:** * **Linezolid Side Effects:** Long-term use (>2 weeks) can lead to **bone marrow suppression** (thrombocytopenia is most common) and **optic/peripheral neuropathy**. * **Drug Interaction:** Linezolid is a weak non-selective **MAO inhibitor**. It can precipitate **Serotonin Syndrome** if co-administered with SSRIs. * **VRE Mechanism:** Resistance to Vancomycin occurs due to the alteration of the D-Ala-D-Ala peptidoglycan terminus to **D-Ala-D-Lac** or D-Ala-D-Ser.

Q: A 30-year-old female with PCOD, on treatment, presented with complaints of hirsutism. She was given a topical cream that inhibits the ornithine decarboxylase enzyme. Which of the following parasitic infections can be managed with this drug?

West African trypanosomiasis. ### Explanation **1. Understanding the Drug (Eflornithine)** The drug described is **Eflornithine**. In dermatology, it is used topically to treat female hirsutism because it inhibits **ornithine decarboxylase (ODC)**, an enzyme essential for polyamine synthesis required for hair follicle growth. Systemically, Eflornithine is a potent antiprotozoal agent. **2. Why West African Trypanosomiasis is Correct** Eflornithine is the drug of choice for the second stage (meningoencephalitic stage) of **West African Trypanosomiasis** caused by *Trypanosoma brucei gambiense*. It acts as a "suicide inhibitor" of ODC in the parasite. Since *T. b. gambiense* has a slow turnover rate for ODC, the drug effectively halts its replication. **3. Why Other Options are Incorrect** * **East African Trypanosomiasis (*T. b. rhodesiense*):** Eflornithine is **ineffective** here because this subspecies has a rapid turnover of the ODC enzyme, allowing it to bypass the drug's effects. Suramin or Melarsoprol are used instead. * **South American Trypanosomiasis (Chagas Disease):** Caused by *Trypanosoma cruzi*. The treatment of choice is Benznidazole or Nifurtimox. * **Visceral Leishmaniasis (Kala-azar):** Treated with Liposomal Amphotericin B (drug of choice), Miltefosine, or Paromomycin. **Clinical Pearls for NEET-PG:** * **Eflornithine** is nicknamed "the resurrection drug" because of its dramatic effect on patients in comatose states of African Sleeping Sickness. * **Route of Administration:** Topical for hirsutism; Intravenous for Sleeping Sickness. * **Mechanism:** Irreversible inhibition of Ornithine Decarboxylase. * **Side effects:** Anemia, leukopenia, and seizures (when given systemically).

Q: A diabetic patient presents with fungal infection of sinuses and peri-orbital region with significant visual impairment. What is the best drug for treatment of this patient?

Amphotericin B. ### Explanation **Correct Option: A (Amphotericin B)** The clinical presentation of a diabetic patient with sinus and peri-orbital involvement (often presenting as black eschar or rapid tissue necrosis) is highly suggestive of **Mucormycosis** (Zygomycosis). This is a medical emergency. **Amphotericin B** is the drug of choice for Mucormycosis because it has the broadest spectrum of activity against most systemic fungi, including *Mucor* and *Rhizopus* species. It works by binding to ergosterol in the fungal cell membrane, creating pores that lead to cell death. In such invasive cases, **Liposomal Amphotericin B** is preferred due to its lower nephrotoxicity and better CNS/tissue penetration. **Why other options are incorrect:** * **Itraconazole (B):** While effective for dermatophytosis and certain systemic infections like Histoplasmosis, it has **no activity** against Mucormycosis. * **Ketoconazole (C):** This is an older imidazole primarily used topically or for Cushing’s syndrome; it is not indicated for invasive, life-threatening systemic fungal infections. * **Broad-spectrum antibiotics (D):** These target bacteria, not fungi. In fact, their use can sometimes predispose a patient to fungal overgrowth by altering normal flora. **High-Yield Clinical Pearls for NEET-PG:** * **Mucormycosis Triad:** Uncontrolled Diabetes (Ketoacidosis), Rhino-orbital-cerebral involvement, and Broad non-septate hyphae (branching at right angles) on biopsy. * **Amphotericin B Side Effects:** "Shake and Bake" (fever/chills), nephrotoxicity (renal tubular acidosis Type 1), and hypokalemia. * **Newer Alternative:** **Isavuconazole** and **Posaconazole** are the only azoles effective against Mucormycosis and are used as step-down therapy or in patients intolerant to Amphotericin B.

Q: Minocycline causes discoloration of:

Both. **Explanation:** **Minocycline**, a semi-synthetic second-generation Tetracycline, is unique due to its high lipid solubility [2], [3]. Unlike other tetracyclines that primarily affect calcifying tissues during development, minocycline can cause hyperpigmentation in adults across various tissues. 1. **Why "Both" is correct:** * **Teeth:** Minocycline causes intrinsic staining of **fully formed adult teeth**. This occurs via two mechanisms: it binds to plasma proteins that are then deposited in the dentin, and it can also be secreted in saliva, causing extrinsic staining through oxidation. * **Palate:** It frequently causes a characteristic **blue-grey/muddy-brown pigmentation** of the hard palate and oral mucosa. This is due to the deposition of iron-containing pigments or metabolic byproducts in the connective tissue. 2. **Analysis of Options:** * **Option A & B:** While both are true individually, they are incomplete. Minocycline is notorious for affecting both dental structures and mucosal surfaces (palate, gingiva, and tongue). 3. **NEET-PG High-Yield Pearls:** * **Mechanism of Action:** Inhibits protein synthesis by binding to the **30S ribosomal subunit** [3]. * **Tissue Distribution:** Due to high lipid solubility, it achieves high concentrations in **saliva and tears** (useful for treating meningococcal carrier states) [1], [2]. * **Specific Side Effects:** * **Vestibular Toxicity:** Causes vertigo, ataxia, and nausea (unique to minocycline) [1], [4]. * **Skin Pigmentation:** Can cause blue-grey discoloration in scars, shins, and sun-exposed areas. * **Drug-Induced Lupus:** Minocycline is a known trigger for systemic lupus-like syndrome. * **Contraindication:** Like all tetracyclines, it is contraindicated in pregnancy and children under 8 years due to bone growth inhibition and enamel hypoplasia [3].

Q: For new pulmonary tuberculosis cases, which drug used in the initiation phase is stopped when the continuation phase begins?

Pyrazinamide. ### Explanation In the management of new pulmonary tuberculosis (TB) cases under the **RNTCP/NTEP guidelines**, the treatment is divided into two phases: the **Intensive (Initiation) Phase** and the **Continuation Phase**. **Why Pyrazinamide is the correct answer:** The standard regimen for a new case is **2HRZE + 4HRE** (or 4HR depending on specific guidelines). * **Intensive Phase (2 months):** Isoniazid (H), Rifampicin (R), Pyrazinamide (Z), and Ethambutol (E) are administered. * **Continuation Phase (4 months):** Only Isoniazid, Rifampicin, and Ethambutol (in some protocols) are continued. **Pyrazinamide** is stopped after the first 2 months because its primary role is to kill **slowly multiplying intracellular bacilli** (sterilizing action) in the acidic environment of macrophages. Once this initial "sterilization" is achieved, it is no longer required for the long-term elimination of dormant bacilli. **Analysis of Incorrect Options:** * **B. Isoniazid & C. Rifampicin:** These are the "backbone" of TB therapy. They are bactericidal and must be continued throughout both phases to ensure a cure and prevent relapse. * **A. Ethambutol:** In the current NTEP daily regimen, Ethambutol is often continued into the continuation phase along with H and R to prevent the development of drug resistance, especially in areas with high baseline isoniazid resistance. **High-Yield Clinical Pearls for NEET-PG:** * **Pyrazinamide** is the most hepatotoxic of the first-line drugs and can cause **hyperuricemia** (leading to gouty arthritis). * **Mechanism of Action:** Pyrazinamide is a prodrug converted to **pyrazinoic acid** by the enzyme *pyrazinamidase*. * **Site of Action:** It is most active in an **acidic pH** (intracellularly). * **Visual Side Effects:** Remember **Ethambutol** causes optic neuritis (red-green color blindness), while **Rifampicin** causes orange-colored secretions.

Q: Which of the following is NOT a type of renal damage caused by amphotericin B?

Glomerulonephritis. Amphotericin B is notorious for its dose-dependent nephrotoxicity, which occurs via two primary mechanisms: direct toxicity to the renal tubular epithelium and induction of renal vasoconstriction. **Explanation of the Correct Option:** **C. Glomerulonephritis:** This is an inflammatory process typically involving immune complexes or direct basement membrane damage. Amphotericin B does **not** cause glomerulonephritis. Its renal damage is primarily tubular and vascular in nature, rather than glomerular inflammation. **Explanation of Incorrect Options:** * **A. Azotemia:** This is the most common manifestation. Amphotericin B causes constriction of the afferent arterioles, leading to decreased renal blood flow and GFR, which results in a rise in serum creatinine and BUN. * **B. Renal Tubular Acidosis (RTA):** Amphotericin B increases the permeability of the distal tubular membrane. This leads to a "leak" of hydrogen ions, causing **Type 1 (Distal) RTA**. * **D. Hypokalemia:** Due to increased membrane permeability in the distal tubules and collecting ducts, there is significant wasting of potassium and magnesium. This electrolyte imbalance is a hallmark side effect. **High-Yield Clinical Pearls for NEET-PG:** * **Liposomal Amphotericin B:** Developed to reduce nephrotoxicity by targeting the drug to the reticuloendothelial system rather than the kidneys. * **Saline Loading:** Pre-infusion with 1 liter of normal saline is the standard clinical practice to "wash out" the drug and minimize the risk of azotemia. * **Anemia:** Amphotericin B also causes normocytic normochromic anemia due to decreased erythropoietin production by the damaged kidneys.

Q: Which of the following drugs is highly vestibulotoxic?

Streptomycin. Aminoglycosides are the most common cause of drug-induced ototoxicity, but they exhibit selective toxicity toward different parts of the inner ear. **Explanation of the Correct Answer:** **Streptomycin** and **Gentamicin** are primarily **vestibulotoxic**. They selectively damage the type I sensory hair cells of the vestibular end organs (semicircular canals and otolith organs). Because of this specific vestibulotoxicity, Streptomycin was historically used (and Gentamicin is currently used) in the chemical ablation of the labyrinth for treating Meniere’s disease. **Explanation of Incorrect Options:** * **Cisplatin:** This is a potent chemotherapeutic agent that is primarily **cochleotoxic**. It causes permanent, bilateral, high-frequency sensorineural hearing loss (SNHL) by damaging the outer hair cells of the organ of Corti. * **Dihydrostreptomycin:** Unlike its parent drug Streptomycin, this derivative is highly **cochleotoxic** and is notorious for causing severe, unpredictable hearing loss. It is rarely used clinically today for this reason. * **Quinine:** This antimalarial drug causes **reversible** ototoxicity. It typically presents with tinnitus, hearing loss, and dizziness (Cinchonism), but the symptoms usually subside once the drug is discontinued. **NEET-PG High-Yield Pearls:** 1. **Vestibulotoxic Aminoglycosides:** Streptomycin, Gentamicin. 2. **Cochleotoxic Aminoglycosides:** Amikacin, Neomycin, Kanamycin, Dihydrostreptomycin. 3. **Loop Diuretics (e.g., Furosemide):** Cause ototoxicity by affecting the *stria vascularis*; toxicity is usually reversible but can be permanent in renal failure. 4. **Topical Ototoxicity:** Neomycin and Polymyxin B should be avoided if the tympanic membrane is perforated. 5. **Monitoring:** High-frequency audiometry is the earliest indicator of cochleotoxicity.

Q: A patient's history notes a documented severe reaction to penicillin. What other antibiotic is likely to cross-react and therefore should be avoided in this patient?

Cephalosporins. **Explanation:** The core concept behind this question is **cross-reactivity** among beta-lactam antibiotics [1]. Penicillins and Cephalosporins both share a common **beta-lactam ring** structure [1]. In patients with a documented severe (Type I, IgE-mediated) hypersensitivity to penicillin, there is a risk of cross-reactivity with cephalosporins (historically cited at 10%, though modern studies suggest it is closer to 1-3%, particularly with first-generation agents) [2]. Due to the potential for life-threatening anaphylaxis, cephalosporins are generally avoided if the penicillin reaction was severe [2]. **Analysis of Options:** * **A. Aminoglycosides (e.g., Gentamicin):** These are chemically unrelated to beta-lactams. They inhibit protein synthesis via the 30S ribosomal subunit and do not cross-react with penicillins. * **B & D. Macrolides (Azithromycin/Erythromycin):** These are the drugs of choice for patients allergic to penicillin. They contain a macrocyclic lactone ring and inhibit the 50S subunit; they have no structural similarity to penicillins. **High-Yield NEET-PG Pearls:** * **Structural Basis:** Cross-reactivity is primarily determined by the **R1 side chain** similarity rather than the beta-lactam ring itself [2]. * **Generation Matters:** Cross-reactivity is highest with 1st-generation cephalosporins (e.g., Cephalexin) and negligible with 3rd or 4th-generation agents [2]. * **Monobactams:** **Aztreonam** is the only beta-lactam that typically does *not* cross-react with penicillins (except for a specific cross-sensitivity with Ceftazidime due to identical side chains). * **Carbapenems:** These also carry a small risk (<1%) of cross-reactivity and should be used with caution.

Question 1

Which antifungal agent is also used as a chemotherapeutic agent for cancer?

Accepted Answer

Flucytosine

Answer

Nystatin

Answer

Voriconazole

Answer

Terbinafine

Question 2

Which anti-tubercular drug is not typically given to children under 6 years of age?

Accepted Answer

Ethambutol

Answer

Isoniazid

Answer

Streptomycin

Answer

Rifampicin

Question 3

In a patient with culture-positive enterococcal endocarditis who has failed to respond to vancomycin due to resistance, what is the most likely effective treatment?

Accepted Answer

Linezolid

Answer

Clarithromycin

Answer

Minocycline

Answer

Ticarcillin

Question 4

A 30-year-old female with PCOD, on treatment, presented with complaints of hirsutism. She was given a topical cream that inhibits the ornithine decarboxylase enzyme. Which of the following parasitic infections can be managed with this drug?

Accepted Answer

West African trypanosomiasis

Answer

East African trypanosomiasis

Answer

South American trypanosomiasis

Answer

Visceral leishmaniasis

Question 5

A diabetic patient presents with fungal infection of sinuses and peri-orbital region with significant visual impairment. What is the best drug for treatment of this patient?

Accepted Answer

Amphotericin B

Answer

Itraconazole

Answer

Ketoconazole

Answer

Broad spectrum antibiotics

Question 6

Minocycline causes discoloration of:

Accepted Answer

Both

Answer

Teeth

Answer

Palate

Answer

None

Question 7

For new pulmonary tuberculosis cases, which drug used in the initiation phase is stopped when the continuation phase begins?

Accepted Answer

Pyrazinamide

Answer

Ethambutol

Answer

Isoniazid

Answer

Rifampicin

Question 8

Which of the following is NOT a type of renal damage caused by amphotericin B?

Accepted Answer

Glomerulonephritis

Answer

Azotemia

Answer

Renal tubular acidosis

Answer

Hypokalemia

Question 9

Which of the following drugs is highly vestibulotoxic?

Accepted Answer

Streptomycin

Answer

Cisplatin

Answer

Dihydrostreptomycin

Answer

Quinine

Question 10

A patient's history notes a documented severe reaction to penicillin. What other antibiotic is likely to cross-react and therefore should be avoided in this patient?

Accepted Answer

Cephalosporins

Answer

Aminoglycosides

Answer

Azithromycin

Answer

Erythromycin

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?